The newly presented therapy showcases an innovative shift toward understanding and addressing the root causes of cellular dysfunction in cancer through mitochondrial restoration. For India, where cancer rates are rising and access to advanced therapies remains uneven across regions, such developments hold potential meaning. If further validated and globally adopted, this study could pave the way for more accessible and effective therapeutic approaches benefitting millions affected by various types of cancers. It might also spark collaborative research opportunities between Indian institutions and global counterparts working on precision medicine while aligning with India’s push toward innovation in healthcare.